In prostate cancer (PCa), METTL3 induces homeobox C6 (HOXC6) m6A modification to stabilize its expression and promote cancer cell proliferation, invasion, migration, stemness, and glycolysis (82). The gene discussed is METTL3; the disease is posterior cortical atrophy.